20040920
 Health Brief -- Pfizer Inc.: Deal Is Reached With Medarex To Discover Antibody Products   The Wall Street Journal,  Sep 21, 2004  Pfizer Inc. and Medarex Inc. agreed to collaborate on the discovery and development of as many as 50 antibody products over 10 years. The companies also cross-licensed some patents related to their antibody programs for patients with advanced prostate cancer. Medarex said Pfizer will make an initial cash payment of $80 million.   
